ArticleInternational immunopharmacology2022

Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic.

Patricia J McLaughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.